Free Trial

H.B. Fuller (FUL) Competitors

H.B. Fuller logo
$72.63 -0.80 (-1.09%)
(As of 12/16/2024 ET)

FUL vs. ALB, CE, BCPC, NEU, ASH, SXT, IOSP, KWR, MTX, and SCL

Should you be buying H.B. Fuller stock or one of its competitors? The main competitors of H.B. Fuller include Albemarle (ALB), Celanese (CE), Balchem (BCPC), NewMarket (NEU), Ashland (ASH), Sensient Technologies (SXT), Innospec (IOSP), Quaker Chemical (KWR), Minerals Technologies (MTX), and Stepan (SCL). These companies are all part of the "specialty chemicals" industry.

H.B. Fuller vs.

Albemarle (NYSE:ALB) and H.B. Fuller (NYSE:FUL) are both basic materials companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends, earnings, media sentiment and community ranking.

H.B. Fuller has a net margin of 5.15% compared to Albemarle's net margin of -28.80%. H.B. Fuller's return on equity of 13.39% beat Albemarle's return on equity.

Company Net Margins Return on Equity Return on Assets
Albemarle-28.80% 1.67% 0.84%
H.B. Fuller 5.15%13.39%4.97%

Albemarle has a beta of 1.56, indicating that its stock price is 56% more volatile than the S&P 500. Comparatively, H.B. Fuller has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.

92.9% of Albemarle shares are owned by institutional investors. Comparatively, 95.9% of H.B. Fuller shares are owned by institutional investors. 0.4% of Albemarle shares are owned by company insiders. Comparatively, 2.0% of H.B. Fuller shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Albemarle presently has a consensus price target of $114.47, suggesting a potential upside of 15.02%. H.B. Fuller has a consensus price target of $97.67, suggesting a potential upside of 34.47%. Given H.B. Fuller's stronger consensus rating and higher probable upside, analysts clearly believe H.B. Fuller is more favorable than Albemarle.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Albemarle
1 Sell rating(s)
15 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.23
H.B. Fuller
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Albemarle has higher revenue and earnings than H.B. Fuller. Albemarle is trading at a lower price-to-earnings ratio than H.B. Fuller, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Albemarle$6.50B1.80$1.57B-$16.75-5.94
H.B. Fuller$3.55B1.12$144.91M$3.2422.42

Albemarle pays an annual dividend of $1.62 per share and has a dividend yield of 1.6%. H.B. Fuller pays an annual dividend of $0.89 per share and has a dividend yield of 1.2%. Albemarle pays out -9.7% of its earnings in the form of a dividend. H.B. Fuller pays out 27.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Albemarle has increased its dividend for 30 consecutive years and H.B. Fuller has increased its dividend for 56 consecutive years. Albemarle is clearly the better dividend stock, given its higher yield and lower payout ratio.

Albemarle received 458 more outperform votes than H.B. Fuller when rated by MarketBeat users. Likewise, 62.88% of users gave Albemarle an outperform vote while only 56.03% of users gave H.B. Fuller an outperform vote.

CompanyUnderperformOutperform
AlbemarleOutperform Votes
774
62.88%
Underperform Votes
457
37.12%
H.B. FullerOutperform Votes
316
56.03%
Underperform Votes
248
43.97%

In the previous week, Albemarle and Albemarle both had 2 articles in the media. Albemarle's average media sentiment score of 0.68 beat H.B. Fuller's score of 0.22 indicating that Albemarle is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Albemarle
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
H.B. Fuller
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral

Summary

Albemarle and H.B. Fuller tied by winning 10 of the 20 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FUL vs. The Competition

MetricH.B. FullerAdhesives & sealants IndustryMaterials SectorNYSE Exchange
Market Cap$3.97B$3.50B$2.71B$19.78B
Dividend Yield1.20%0.72%5.22%3.50%
P/E Ratio22.4218.82110.7843.83
Price / Sales1.122.98882,069.3717.70
Price / Cash10.6726.5223.3721.72
Price / Book2.234.103.535.50
Net Income$144.91M$79.87M$146.20M$986.12M
7 Day Performance-4.21%-2.18%-2.07%-1.99%
1 Month Performance-4.38%-2.68%5.60%1.97%
1 Year Performance-11.19%26.67%21.51%17.25%

H.B. Fuller Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FUL
H.B. Fuller
4.204 of 5 stars
$72.63
-1.1%
$97.67
+34.5%
-10.1%$3.97B$3.55B22.427,200
ALB
Albemarle
3.7087 of 5 stars
$109.91
+4.7%
$114.47
+4.2%
-32.4%$12.92B$9.62B-6.799,000Ex-Dividend
CE
Celanese
4.9979 of 5 stars
$74.53
+5.7%
$116.56
+56.4%
-54.9%$8.15B$10.94B7.1012,410Short Interest ↓
BCPC
Balchem
4.5282 of 5 stars
$176.89
-0.4%
$190.00
+7.4%
+25.3%$5.75B$922.44M47.721,302Dividend Increase
Short Interest ↓
Positive News
NEU
NewMarket
2.2561 of 5 stars
$546.47
+1.7%
N/A-3.4%$5.25B$2.70B11.932,000Positive News
ASH
Ashland
4.8528 of 5 stars
$77.02
+2.0%
$103.29
+34.1%
-12.3%$3.63B$2.11B22.533,200Short Interest ↑
Analyst Revision
SXT
Sensient Technologies
3.4915 of 5 stars
$78.70
+0.8%
$85.00
+8.0%
+17.9%$3.33B$1.46B37.373,956Positive News
IOSP
Innospec
3.431 of 5 stars
$117.88
+1.5%
N/A-3.3%$2.94B$1.95B20.272,400Short Interest ↑
Positive News
KWR
Quaker Chemical
3.6327 of 5 stars
$159.56
+1.7%
$187.33
+17.4%
-26.0%$2.84B$1.95B23.014,400Short Interest ↑
MTX
Minerals Technologies
2.95 of 5 stars
$81.36
+2.1%
N/A+20.6%$2.59B$2.12B16.884,070Positive News
SCL
Stepan
3.9735 of 5 stars
$76.89
+2.6%
N/A-20.0%$1.73B$2.33B37.272,389News Coverage
Positive News

Related Companies and Tools


This page (NYSE:FUL) was last updated on 12/16/2024 by MarketBeat.com Staff
From Our Partners